Business Description
Cumberland Pharmaceuticals is a US-based company that develops, acquires, and sells prescription medications across several medical specialties. Its portfolio includes injectable treatments for conditions such as acetaminophen poisoning, bacterial infections, and abnormal sodium levels, as well as products addressing pain, fever, constipation, nausea, and stomach infections. The company serves hospitals and specialist care providers across multiple international markets, including China, South Korea, Russia, and Australia, and is also advancing a clinical-stage drug called ifetroban for several serious conditions. Founded in 1999 and headquartered in Nashville, Tennessee, Cumberland operates with a strategic partnership with WinHealth Pharma Group to support its presence in key global markets.
